| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
53,856,000 |
| Market
Cap: |
566.03(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.17 - $22.52 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Consumer Non-Durables |
| Level
III Sector: |
Packaging & Containers |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cryoport is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Co. operates in two reportable segments: Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment provides a platform of temperature-controlled solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and cold chain logistics capability. The Global Bioservices segment provides a temperature-controlled sample management solution to the life science industry, including specimen storage, sample processing, collection, and retrieval.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
85,488 |
87,288 |
115,663 |
307,364 |
| Total Sell Value |
$1,302,492 |
$1,331,504 |
$1,735,311 |
$5,960,369 |
| Total People Sold |
6 |
7 |
7 |
7 |
| Total Sell Transactions |
12 |
14 |
16 |
28 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stefanovich Robert |
Chief Financial Officer |
• – – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,666 |
125,816 |
|
- |
|
| Shelton Jerrell |
President, CEO |
• • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
640,674 |
|
- |
|
| Hariri Robert J |
Director |
– • – |
2023-12-14 |
4 |
S |
$16.89 |
$13,512 |
D/D |
(800) |
12,716 |
|
1% |
|
| Hariri Robert J |
Director |
– • – |
2023-12-11 |
4 |
S |
$15.50 |
$15,500 |
D/D |
(1,000) |
13,516 |
|
-8% |
|
| Sawicki Mark W |
Chief Scientific Officer |
• – – |
2023-09-12 |
4 |
OE |
$12.79 |
$12,790 |
D/D |
1,000 |
73,125 |
|
- |
|
| Hariri Robert J |
Director |
– • – |
2023-09-06 |
4 |
S |
$13.60 |
$20,400 |
D/D |
(1,500) |
14,516 |
|
-6% |
|
| Shelton Jerrell |
See Remarks |
• • – |
2023-09-01 |
4 |
S |
$14.27 |
$383,407 |
D/D |
(26,875) |
632,424 |
|
-4% |
|
| Shelton Jerrell |
See Remarks |
• • – |
2023-09-01 |
4 |
OE |
$1.87 |
$100,980 |
D/D |
54,000 |
659,299 |
|
- |
|
| Stefanovich Robert |
Chief Financial Officer |
• – – |
2023-08-29 |
4 |
OE |
$3.07 |
$49,120 |
D/D |
16,000 |
123,150 |
|
- |
|
| Mandalam Ramkumar |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
18,016 |
|
- |
|
| Berman Richard J |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
108,105 |
|
- |
|
| Zecchini Edward J |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
53,039 |
|
- |
|
| Hariri Robert J |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
16,016 |
|
- |
|
| Baddour Linda |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
20,579 |
|
- |
|
| Hancock Daniel M |
Director |
– • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,105 |
22,643 |
|
- |
|
| Berman Richard J |
Director |
– • – |
2023-05-11 |
4 |
S |
$21.51 |
$154,906 |
D/D |
(7,203) |
100,000 |
|
36% |
|
| Shelton Jerrell |
President, CEO |
• • – |
2023-05-10 |
4 |
S |
$21.63 |
$3,053,509 |
D/D |
(141,159) |
605,299 |
|
33% |
|
| Shelton Jerrell |
President, CEO |
• • – |
2023-05-10 |
4 |
OE |
$3.24 |
$927,861 |
D/D |
286,377 |
746,458 |
|
- |
|
| Stefanovich Robert |
Chief Financial Officer |
• – – |
2023-05-10 |
4 |
S |
$21.94 |
$437,023 |
D/D |
(19,918) |
107,150 |
|
33% |
|
| Stefanovich Robert |
Chief Financial Officer |
• – – |
2023-05-10 |
4 |
OE |
$3.24 |
$64,534 |
D/D |
19,918 |
127,068 |
|
- |
|
| Sawicki Mark W |
Chief Scientific Officer |
• – – |
2023-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,455 |
72,125 |
|
- |
|
| Stefanovich Robert |
Chief Financial Officer |
• – – |
2023-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,455 |
107,150 |
|
- |
|
| Shelton Jerrell |
Chief Executive Officer |
• • – |
2023-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
27,092 |
460,081 |
|
- |
|
| Stefanovich Robert |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
S |
$20.79 |
$22,225 |
D/D |
(1,069) |
96,695 |
|
24% |
|
| Sawicki Mark W |
Chief Scientific Officer |
• – – |
2023-03-15 |
4 |
S |
$20.79 |
$28,316 |
D/D |
(1,362) |
61,670 |
|
24% |
|
295 Records found
|
|
Page 2 of 12 |
|
|
0.64 (6.48%) 
